دورية أكاديمية
Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy.
| العنوان: | Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy. |
|---|---|
| المؤلفون: | Knoppert SN; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Keijzer-Veen MG; Department of Pediatric Nephrology, Wilhelmina Children's Hospital, Utrecht, The Netherlands., Valentijn FA; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Lilien MR; Department of Pediatric Nephrology, Wilhelmina Children's Hospital, Utrecht, The Netherlands., van den Berg G; Department of Pediatric Nephrology, Wilhelmina Children's Hospital, Utrecht, The Netherlands., Haveman LM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Stokman MF; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Janssens GO; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., van Kempen S; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Broekhuizen R; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Goldschmeding R; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Nguyen TQ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. |
| المصدر: | The Journal of pathology [J Pathol] 2023 Dec; Vol. 261 (4), pp. 455-464. Date of Electronic Publication: 2023 Oct 04. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Chichester : John Wiley And Sons Original Publication: London, Oliver & Boyd. |
| مواضيع طبية MeSH: | Nephritis, Interstitial*/genetics , Neoplasms*/pathology , Renal Insufficiency, Chronic*/diagnosis , Renal Insufficiency, Chronic*/genetics , Renal Insufficiency, Chronic*/complications, Humans ; Child ; Muramidase/genetics ; Ifosfamide ; In Situ Hybridization, Fluorescence ; Proteinuria/pathology ; Kidney/pathology ; Biopsy ; Cellular Senescence ; Polyploidy |
| مستخلص: | Karyomegalic interstitial nephropathy (KIN) has been reported as an incidental finding in patients with childhood cancer treated with ifosfamide. It is defined by the presence of tubular epithelial cells (TECs) with enlarged, irregular, and hyperchromatic nuclei. Cellular senescence has been proposed to be involved in kidney fibrosis in hereditary KIN patients. We report that KIN could be diagnosed 7-32 months after childhood cancer diagnosis in 6/6 consecutive patients biopsied for progressive chronic kidney disease (CKD) of unknown cause between 2018 and 2021. The morphometry of nuclear size distribution and markers for DNA damage (γH2AX), cell-cycle arrest (p21+, Ki67-), and nuclear lamina decay (loss of lamin B1), identified karyomegaly and senescence features in TECs. Polyploidy was assessed by chromosome fluorescence in situ hybridization (FISH). In all six patients the number of p21-positive TECs far exceeded the typically small numbers of truly karyomegalic cells, and p21-positive TECs contained less lysozyme, testifying to defective resorption, which explains the consistently observed low-molecular-weight (LMW) proteinuria. In addition, polyploidy of TEC was observed to correlate with loss of lysozyme staining. Importantly, in the five patients with the largest nuclei, the percentage of p21-positive TECs tightly correlated with estimated glomerular filtration rate loss between biopsy and last follow-up (R 2 = 0.93, p < 0.01). We conclude that cellular senescence is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with KIN and appears to be a prevalent cause of otherwise unexplained CKD and LMW proteinuria in children treated with DNA-damaging and cell stress-inducing therapy including ifosfamide. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. (© 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.) |
| References: | McCulloch T, Prayle A, Lunn A, et al. Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy. Pediatr Nephrol 2011; 26: 1163-1166. Burry AF. Extreme dysplasia in renal epithelium of a young woman dying from hepatocarcinoma. J Pathol 1974; 113: 147-150. Mihatsch MJ, Gudat F, Zollinger HU, et al. Systemic karyomegaly associated with chronic interstitial nephritis. A new disease entity? Clin Nephrol 1979; 12: 54-62. Zhou W, Otto EA, Cluckey A, et al. FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet 2012; 44: 910-915. Godin M, Francois A, Le Roy F, et al. Karyomegalic interstitial nephritis. Am J Kidney Dis 1996; 27: 166. Richardson SO, Huibers MMH, de Weger RA, et al. One-fits-all pretreatment protocol facilitating fluorescence in situ hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slides. Mol Cytogenet 2019; 12: 27. Bankhead P, Loughrey MB, Fernández JA, et al. QuPath: open source software for digital pathology image analysis. Sci Rep 2017; 7: 16878. Bhandari S, Kalowski S, Collett P, et al. Karyomegalic nephropathy: an uncommon cause of progressive renal failure. Nephrol Dial Transplant 2002; 17: 1914-1920. Knoppert SN, Valentijn FA, Nguyen TQ, et al. Cellular senescence and the kidney: potential therapeutic targets and tools. Front Pharmacol 2019; 10: 770. Kuo LJ, Yang L-X. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo 2008; 22: 305-309. Lazzeri E, Angelotti ML, Peired A, et al. Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury. Nat Commun 2018; 9: 1344. De Chiara L, Conte C, Semeraro R, et al. Tubular cell polyploidy protects from lethal acute kidney injury but promotes consequent chronic kidney disease. Nat Commun 2022; 13: 5805. Jayasurya R, Srinivas BH, Ponraj M, et al. Karyomegalic interstitial nephropathy following ifosfamide therapy. Indian J Nephrol 2016; 26: 294-297. Matsuura T, Wakino S, Yoshifuji A, et al. Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid. CEN Case Rep 2014; 3: 226-231. Stöhr W, Paulides M, Bielack S, et al. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the late effects surveillance system. Pediatr Blood Cancer 2007; 48: 447-452. Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG late effects group study. United Kingdom Children's cancer study group. Br J Cancer 2000; 82: 1636-1645. Loebstein R, Atanackovic G, Bishai R, et al. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 1999; 39: 454-461. Skinner R, Parry A, Price L, et al. Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose. Pediatr Blood Cancer 2010; 54: 983-989. Tang C, Livingston MJ, Safirstein R, et al. Cisplatin nephrotoxicity: new insights and therapeutic implications. Nat Rev Nephrol 2023; 19: 53-72. Radha S, Tameem A, Rao BS. Karyomegalic interstitial nephritis with focal segmental glomerulosclerosis: a rare association. Indian J Nephrol 2014; 24: 117-119. Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol 2018; 28: 436-453. Docherty M-H, O'Sullivan ED, Bonventre JV, et al. Cellular senescence in the kidney. J Am Soc Nephrol 2019; 30: 726-736. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer 2015; 15: 397-408. Willits I, Price L, Parry A, et al. Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer. Br J Cancer 2005; 92: 1626-1635. Wang W-J, Cai G-Y, Chen X-M. Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease. Oncotarget 2017; 8: 64520-64533. Lazzeri E, Angelotti ML, Conte C, et al. Surviving acute organ failure: cell polyploidization and progenitor proliferation. Trends Mol Med 2019; 25: 366-381. Kooijmans EC, Bökenkamp A, Tjahjadi NS, et al. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database Syst Rev 2019; 3: CD008944. Calderon-Margalit R, Pleniceanu O, Tzur D, et al. Childhood cancer and the risk of ESKD. J Am Soc Nephrol 2021; 32: 495-501. Green DM, Wang M, Krasin M, et al. Kidney function after treatment for childhood cancer: a report from the St. Jude lifetime cohort study. J Am Soc Nephrol 2021; 32: 983-993. Levin A, Stevens PE, Bilous RW, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150. |
| معلومات مُعتمدة: | 170KG20 Nierstichting; CP1805 Nierstichting |
| فهرسة مساهمة: | Keywords: DNA damage; cellular senescence; childhood cancer patients; chronic kidney disease; ifosfamide; karyomegalic interstitial nephropathy |
| المشرفين على المادة: | EC 3.2.1.17 (Muramidase) UM20QQM95Y (Ifosfamide) |
| تواريخ الأحداث: | Date Created: 20231004 Date Completed: 20231113 Latest Revision: 20240404 |
| رمز التحديث: | 20240404 |
| DOI: | 10.1002/path.6202 |
| PMID: | 37792603 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1096-9896 |
|---|---|
| DOI: | 10.1002/path.6202 |